The BTK Inhibitor, Bgb-3111, Is Safe, Tolerable, and Highly Active in Patients with Relapsed/ Refractory B-Cell Malignancies: Initial Report of a Phase 1 First-in-Human TrialConstantine S. Tam, Andrew W. Roberts, Michael Gilbertson et al.|Blood|2015Cited by 111
Testes-specific protease 50 (TSP50) promotes invasion and metastasis by inducing EMT in gastric cancerQinghua Cao, Ling Xue|BMC Cancer|2018Cited by 44
Twice Daily Dosing with the Highly Specific BTK Inhibitor, Bgb-3111, Achieves Complete and Continuous BTK Occupancy in Lymph Nodes, and Is Associated with Durable Responses in Patients (pts) with Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)Constantine S. Tam, Andrew W. Roberts, Stephen Opat et al.|Blood|2016Cited by 37
MicroRNA-382-5p is involved in pulmonary inflammation induced by fine particulate matter exposureXinwei Zhang, Rui Chen, Yanshu Zhang et al.|Environmental Pollution|2020Cited by 26
Overexpression of Testes-Specific Protease 50 (TSP50) Predicts Poor Prognosis in Patients with Gastric CancerFang Liu, Rongcheng Luo, Qinghua Cao et al.|Gastroenterology Research and Practice|2014Cited by 17